118 related articles for article (PubMed ID: 17046138)
1. Mutation of acetylcholinesterase to enhance oxime-assisted catalytic turnover of methylphosphonates.
Kovarik Z; Radić Z; Berman HA; Taylor P
Toxicology; 2007 Apr; 233(1-3):79-84. PubMed ID: 17046138
[TBL] [Abstract][Full Text] [Related]
2. Mutant cholinesterases possessing enhanced capacity for reactivation of their phosphonylated conjugates.
Kovarik Z; Radić Z; Berman HA; Simeon-Rudolf V; Reiner E; Taylor P
Biochemistry; 2004 Mar; 43(11):3222-9. PubMed ID: 15023072
[TBL] [Abstract][Full Text] [Related]
3. Phosphoryl oxime inhibition of acetylcholinesterase during oxime reactivation is prevented by edrophonium.
Luo C; Saxena A; Smith M; Garcia G; Radić Z; Taylor P; Doctor BP
Biochemistry; 1999 Aug; 38(31):9937-47. PubMed ID: 10433700
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of oxime reactivation of acetylcholinesterase analyzed by chirality and mutagenesis.
Wong L; Radic Z; Brüggemann RJ; Hosea N; Berman HA; Taylor P
Biochemistry; 2000 May; 39(19):5750-7. PubMed ID: 10801325
[TBL] [Abstract][Full Text] [Related]
5. Acetylcholinesterase: converting a vulnerable target to a template for antidotes and detection of inhibitor exposure.
Taylor P; Kovarik Z; Reiner E; Radić Z
Toxicology; 2007 Apr; 233(1-3):70-8. PubMed ID: 17196318
[TBL] [Abstract][Full Text] [Related]
6. The reactivation of tabun-inhibited mutant AChE with Ortho-7: steered molecular dynamics and quantum chemical studies.
Lo R; Chandar NB; Ghosh S; Ganguly B
Mol Biosyst; 2016 Apr; 12(4):1224-31. PubMed ID: 26879641
[TBL] [Abstract][Full Text] [Related]
7. Asymmetric fluorogenic organophosphates for the development of active organophosphate hydrolases with reversed stereoselectivity.
Amitai G; Adani R; Yacov G; Yishay S; Teitlboim S; Tveria L; Limanovich O; Kushnir M; Meshulam H
Toxicology; 2007 Apr; 233(1-3):187-98. PubMed ID: 17129656
[TBL] [Abstract][Full Text] [Related]
8. Molecular modeling and in vitro reactivation study between the oxime BI-6 and acetylcholinesterase inhibited by different nerve agents.
Giacoppo JO; C C França T; Kuča K; da Cunha EF; Abagyan R; Mancini DT; Ramalho TC
J Biomol Struct Dyn; 2015 Sep; 33(9):2048-58. PubMed ID: 25407587
[TBL] [Abstract][Full Text] [Related]
9. In vitro reactivation of acetylcholinesterase using the oxime K027.
Kuca K; Kassa J
Vet Hum Toxicol; 2004 Feb; 46(1):15-8. PubMed ID: 14748409
[TBL] [Abstract][Full Text] [Related]
10. HI-6 assisted catalytic scavenging of VX by acetylcholinesterase choline binding site mutants.
Maček Hrvat N; Žunec S; Taylor P; Radić Z; Kovarik Z
Chem Biol Interact; 2016 Nov; 259(Pt B):148-153. PubMed ID: 27083141
[TBL] [Abstract][Full Text] [Related]
11. Active site mutant acetylcholinesterase interactions with 2-PAM, HI-6, and DDVP.
Kovarik Z; Ciban N; Radić Z; Simeon-Rudolf V; Taylor P
Biochem Biophys Res Commun; 2006 Apr; 342(3):973-8. PubMed ID: 16598855
[TBL] [Abstract][Full Text] [Related]
12. In silico studies on the role of mutant Y337A to reactivate tabun inhibited mAChE with K048.
Chandar NB; Ghosh S; Lo R; Banjo S; Ganguly B
Chem Biol Interact; 2015 Dec; 242():299-306. PubMed ID: 26494532
[TBL] [Abstract][Full Text] [Related]
13. A common mechanism for resistance to oxime reactivation of acetylcholinesterase inhibited by organophosphorus compounds.
Maxwell DM; Brecht KM; Sweeney RE
Chem Biol Interact; 2013 Mar; 203(1):72-6. PubMed ID: 22982773
[TBL] [Abstract][Full Text] [Related]
14. Modeling of a near-attack conformation of oxime in phosphorylated acetylcholinesterase via a reactivation product, a phosphorylated oxime.
Šinko G
Chem Biol Interact; 2023 Sep; 383():110656. PubMed ID: 37579936
[TBL] [Abstract][Full Text] [Related]
15. Oxime-assisted acetylcholinesterase catalytic scavengers of organophosphates that resist aging.
Cochran R; Kalisiak J; Küçükkilinç T; Radic Z; Garcia E; Zhang L; Ho KY; Amitai G; Kovarik Z; Fokin VV; Sharpless KB; Taylor P
J Biol Chem; 2011 Aug; 286(34):29718-24. PubMed ID: 21730071
[TBL] [Abstract][Full Text] [Related]
16. In vivo oxime administration does not influence Ellman acetylcholinesterase assay results.
Guarisco JA; O'Donnell JC; Skovira JW; McDonough JH; Shih TM
Toxicol Mech Methods; 2009 Sep; 19(6-7):379-85. PubMed ID: 19778238
[TBL] [Abstract][Full Text] [Related]
17. Interactions of oxime reactivators with diethylphosphoryl adducts of human acetylcholinesterase and its mutant derivatives.
Grosfeld H; Barak D; Ordentlich A; Velan B; Shafferman A
Mol Pharmacol; 1996 Sep; 50(3):639-49. PubMed ID: 8794905
[TBL] [Abstract][Full Text] [Related]
18. Structural requirements for effective oximes--evaluation of kinetic in vitro data with phosphylated human AChE and structurally different oximes.
Worek F; Wille T; Koller M; Thiermann H
Chem Biol Interact; 2013 Mar; 203(1):125-8. PubMed ID: 22827894
[TBL] [Abstract][Full Text] [Related]
19. Interactions between xylene-linked carbamoyl bis-pyridinium mono-oximes and organophosphates inhibited-AChE: a kinetic study.
Sharma R; Gupta B; Acharya J; Kaushik MP; Ghosh KK
Toxicology; 2014 Feb; 316():1-8. PubMed ID: 24345352
[TBL] [Abstract][Full Text] [Related]
20. Specificity and orientation of trigonal carboxyl esters and tetrahedral alkylphosphonyl esters in cholinesterases.
Hosea NA; Berman HA; Taylor P
Biochemistry; 1995 Sep; 34(36):11528-36. PubMed ID: 7547883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
